Development of human angiotensin converting enzyme-2 (hACE2) as a strategy to face COVID-19

Detalhes bibliográficos
Autor(a) principal: Silva Junior, Haroldo Cid da
Data de Publicação: 2021
Outros Autores: Martins, Fernanda Otaviano, Pestana, Cristiane Pinheiro, Mansur, Janaina Figueira, Argondizzo, Ana Paula Corrêa, Garcia, Mariana Miguez Tardelli, Esteves, Gabriela dos Santos
Tipo de documento: Artigo de conferência
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/46641
Resumo: Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
id CRUZ_d044fd8ae2420634207811e7d551a826
oai_identifier_str oai:www.arca.fiocruz.br:icict/46641
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Silva Junior, Haroldo Cid daMartins, Fernanda OtavianoPestana, Cristiane PinheiroMansur, Janaina FigueiraArgondizzo, Ana Paula CorrêaGarcia, Mariana Miguez TardelliEsteves, Gabriela dos Santos2021-04-12T14:54:32Z2021-04-12T14:54:32Z2021SILVA JUNIOR, H. C. et al. Development of human angiotensin converting enzyme-2 (hACE2) as a strategy to face COVID-19. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 5., 2021. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2021. p. 65.https://www.arca.fiocruz.br/handle/icict/4664110.35259/isi.2021_46641Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.engFiocruz/Instituto de Tecnologia em ImunobiológicosCOVID-19ACE2SARS-CoV-2ISICOVID-19ACE2SARS-CoV-2International Symposium on ImmunobiologicalsBetacoronavirusDevelopment of human angiotensin converting enzyme-2 (hACE2) as a strategy to face COVID-19info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83108https://www.arca.fiocruz.br/bitstream/icict/46641/1/license.txt155f7d692661a91111cc666068bcb611MD51ORIGINALORT_23.pdfORT_23.pdfapplication/pdf224388https://www.arca.fiocruz.br/bitstream/icict/46641/2/ORT_23.pdf8822bcedf34e894f543693b7c32a34adMD52TEXTORT_23.pdf.txtORT_23.pdf.txtExtracted texttext/plain2773https://www.arca.fiocruz.br/bitstream/icict/46641/3/ORT_23.pdf.txt7cc6ae23ca31db83a42db7500ae7336eMD53icict/466412023-04-26 16:57:50.864oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-04-26T19:57:50Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Development of human angiotensin converting enzyme-2 (hACE2) as a strategy to face COVID-19
title Development of human angiotensin converting enzyme-2 (hACE2) as a strategy to face COVID-19
spellingShingle Development of human angiotensin converting enzyme-2 (hACE2) as a strategy to face COVID-19
Silva Junior, Haroldo Cid da
COVID-19
ACE2
SARS-CoV-2
ISI
COVID-19
ACE2
SARS-CoV-2
International Symposium on Immunobiologicals
Betacoronavirus
title_short Development of human angiotensin converting enzyme-2 (hACE2) as a strategy to face COVID-19
title_full Development of human angiotensin converting enzyme-2 (hACE2) as a strategy to face COVID-19
title_fullStr Development of human angiotensin converting enzyme-2 (hACE2) as a strategy to face COVID-19
title_full_unstemmed Development of human angiotensin converting enzyme-2 (hACE2) as a strategy to face COVID-19
title_sort Development of human angiotensin converting enzyme-2 (hACE2) as a strategy to face COVID-19
author Silva Junior, Haroldo Cid da
author_facet Silva Junior, Haroldo Cid da
Martins, Fernanda Otaviano
Pestana, Cristiane Pinheiro
Mansur, Janaina Figueira
Argondizzo, Ana Paula Corrêa
Garcia, Mariana Miguez Tardelli
Esteves, Gabriela dos Santos
author_role author
author2 Martins, Fernanda Otaviano
Pestana, Cristiane Pinheiro
Mansur, Janaina Figueira
Argondizzo, Ana Paula Corrêa
Garcia, Mariana Miguez Tardelli
Esteves, Gabriela dos Santos
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Silva Junior, Haroldo Cid da
Martins, Fernanda Otaviano
Pestana, Cristiane Pinheiro
Mansur, Janaina Figueira
Argondizzo, Ana Paula Corrêa
Garcia, Mariana Miguez Tardelli
Esteves, Gabriela dos Santos
dc.subject.other.pt_BR.fl_str_mv COVID-19
ACE2
SARS-CoV-2
ISI
topic COVID-19
ACE2
SARS-CoV-2
ISI
COVID-19
ACE2
SARS-CoV-2
International Symposium on Immunobiologicals
Betacoronavirus
dc.subject.en.pt_BR.fl_str_mv COVID-19
ACE2
SARS-CoV-2
International Symposium on Immunobiologicals
dc.subject.decs.pt_BR.fl_str_mv Betacoronavirus
description Os autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
publishDate 2021
dc.date.accessioned.fl_str_mv 2021-04-12T14:54:32Z
dc.date.available.fl_str_mv 2021-04-12T14:54:32Z
dc.date.issued.fl_str_mv 2021
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/conferenceObject
format conferenceObject
status_str publishedVersion
dc.identifier.citation.fl_str_mv SILVA JUNIOR, H. C. et al. Development of human angiotensin converting enzyme-2 (hACE2) as a strategy to face COVID-19. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 5., 2021. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2021. p. 65.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/46641
dc.identifier.doi.none.fl_str_mv 10.35259/isi.2021_46641
identifier_str_mv SILVA JUNIOR, H. C. et al. Development of human angiotensin converting enzyme-2 (hACE2) as a strategy to face COVID-19. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 5., 2021. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2021. p. 65.
10.35259/isi.2021_46641
url https://www.arca.fiocruz.br/handle/icict/46641
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
publisher.none.fl_str_mv Fiocruz/Instituto de Tecnologia em Imunobiológicos
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/46641/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/46641/2/ORT_23.pdf
https://www.arca.fiocruz.br/bitstream/icict/46641/3/ORT_23.pdf.txt
bitstream.checksum.fl_str_mv 155f7d692661a91111cc666068bcb611
8822bcedf34e894f543693b7c32a34ad
7cc6ae23ca31db83a42db7500ae7336e
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324821756477440